Abstract:Objective: To summarize the electroclinical features and prognosis of epilepsy in children with methylmalonic acidetnia (M MA).Methods: The medical records of hospitalized MMA patients associated with epilepsy were retrospectively reviewed. The clinical manifestations, laboratory examination results, and treatment modalities were analyzed.Results: From 63 pediatric inpatients diagnosed as MMA in Peking University First Hospital from June 1996 to December 2009, 27 children (42.9%) associated with epilepsy were enrolled in this study. These 27 patients were also accompanied with other neurological manifestations including mental retardation or regression (n = 22), lethargy (n = 10), increased muscle tone (n = 8), muscle hypotonia (n = 8), recurrent vomiting (n = 4), tremor (n = 2), ataxia (n = 2), and abnormal posture (n = 1). The onset age of seizure ranged from 8 days to 11 years. The seizure types included partial seizure (n = 21), generalized tonic-clonic seizure (n = 5), tonic seizure (n = 3), myoclonic seizure (n = 3), and epileptic spasms (n = 2). Five patients had two or three seizure types. Nine patients (33.3%) had a history of status epilepticus. EEG showed slow background activity in 17 patients, focal or multifocal paroxysmal discharges in 16 patients, generalized paroxysmal discharges in four patients, hypsarrythmia in two patients, and suppression-burst pattern in one patient. Cranial MRI scans showed bilateral cerebral atrophy (n = 14), increased T2 signal intensities in white matter (n = 12), agenesis of corpus callosum = 2), bilateral increased T2 signal intensities or necrosis in basal ganglia (n = 2), and cerebellar atrophy (n = 1). Twenty one patients were M MA combined with homocysteinemia. Seventeen patients were confirmed with cobalamin C disease and one with partial mutase deficiency (mut(-)). Vitamin B12-responsive patients had a better outcome compared with vitamin B12-unresponsive patients.Conclusions: Epilepsy is a common manifestation of patients with MMA. Partial seizure is more common than other seizure types. Urine organic acid analysis should be performed for children with unknown cause of epilepsy combined with other neurological manifestations, so as to promptly identify the etiology and improve the prognosis. (C) 2011 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

[Epilepsy and inborn errors of metabolism]

Metabolic epilepsies: approaches to a diagnostic challenge

Inborn Errors of Metabolism and Epilepsy: Current Understanding, Diagnosis, and Treatment Approaches

Actual Insights into Treatable Inborn Errors of Metabolism Causing Epilepsy

Metabolic etiologies in children with infantile epileptic spasm syndrome: Experience at a tertiary pediatric neurology center

Clinical and biochemical footprints of inherited metabolic diseases. XV. Epilepsies

Inborn errors of metabolism and epilepsy in children

Neonatal seizures as onset of Inborn Errors of Metabolism (IEMs): from diagnosis to treatment. A systematic review

Neonatal seizures: the overlap between diagnosis of metabolic disorders and structural abnormalities. Case report

New treatment paradigms in neonatal metabolic epilepsies

Epilepsy in mitochondrial disorders

Epilepsy in Children with Methylmalonic Acidemia: Electroclinical Features and Prognosis

Treatment and prognosis of developmental delay in children caused by inborn errors of metabolism

Clinical manifestations and prognosis of neonate-onset inborn errors of metabolism

[Neonatal epileptics syndromes]

Epilepsy: Mitochondrial connections to the 'Sacred' disease

Developmental and epileptic encephalopathies

A Rare Presentation Characterized by Epileptic Spasms in ALDH7A1, Pyridox(am)ine-5′-Phosphate Oxidase, and PLPBP Deficiency

Screening of Inherited Metabolic Disorders in Infants with Infantile Spasms

Seizure Characteristics and EEG Features in Intoxication Type and Energy Deficiency Neurometabolic Disorders in the Pediatric Intensive Care Unit: Single-Center Experience Over 10 Years

Profound neonatal hypoglycemia and lactic acidosis caused by pyridoxine-dependent epilepsy